New Key Statistics Module, Z-Score and F-Score
NAS:VERV Key Ratios
| Market Cap $ M | 537.95 |
| Enterprise Value $ M | -33.76 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.88 |
| Price/Sales | 35.78 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11.00 |
| EPS (TTM) $ | -3.12 |
| Beneish M-Score | 1.86 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.15 |
| EV-to-EBITDA | 0.16 |
| PEG | -- |
| Shares Outstanding M | 83.92 |
| Net Margin (%) | -1,701.55 |
| Operating Margin % | -1,897.64 |
| Pre-tax Margin (%) | -1,699.21 |
| Quick Ratio | 17.24 |
| Current Ratio | 17.24 |
| ROA % (ttm) | -30.61 |
| ROE % (ttm) | -38.69 |
| ROIC % (ttm) | -166.12 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.10 |
VERV Number of Guru Trades
VERV Volume of Guru Trades
Gurus Latest Trades with NAS:VERV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VERV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Verve Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VERV
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers